Global Immune system drugs Market Research Report 2017-2022 by Players, Regions, Product Types & Applications

Published: Aug, 2017 | Pages: 129 | Publisher: Data Market Research (DMR)
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

The global Immune system drugs market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

This report offers an overview of the market trends, drivers, and barriers with respect to the Immune system drugs market. It also provides a detailed overview of the market of different regions across United States, Europe, China, Japan, India, Southeast Asia and Others. The report categorizes Immune system drugs market by by Immunosuppressive drugs, by Immunoregulants, and application. Detailed analysis of key players, along with key growth strategies adopted by them is also covered in this report on Immune system drugs market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

This report focuses Global market, it covers details as following:

Key Players
    ABBVIE
    ACCORD HLTHCARE
    AKORN INC
    ALLERGAN
    AMNEAL PHARMS LLC
    ANTARES PHARMA INC
    APOTEX
    ASTELLAS
    BAXTER HLTHCARE
    BAYER HEALTHCARE PHARMS
    DAVA PHARMS INC
    DR REDDYS LABS LTD
    FRESENIUS KABI USA
    GLENMARK GENERICS
    HOSPIRA
    IVAX SUB TEVA PHARMS
    MAYNE PHARMA
    MYLAN
    NOVARTIS
    ROCHE PALO
    SANDOZ
    SANOFI AVENTIS US
    STRIDES PHARMA
    TEVA PHARMS
    VELOXIS PHARMS INC
    VIDARA THERAPEUTICS RESEARCH LTD
    VINTAGE PHARMS LLC
    WATSON LABS
    WEST-WARD PHARMS INT
    ZYDUS PHARMS USA

Key Regions
    North America
        United States
        Canada
    Latin America
        Mexico
        Brazil
        Argentina
        Others
    Europe
        Germany
        United Kingdom
        France
        Italy
        Spain
        Russia
        Netherland
        Others
    Asia & Pacific
        China
        Japan
        India
        Korea
        Australia
        Southeast Asia
            Indonesia
            Thailand
            Philippines
            Vietnam
            Singapore
            Malaysia
            Others
    Africa & Middle East
        South Africa
        Egypt
        Turkey
        Saudi Arabia
        Iran
        Others

Main types of products
Immune system drugs Market, by Immunosuppressive drugs
    Azathioprine
    Tripterygium Glycosides
    Cyclosporine
    Sandimmune
    Ciclosporin
    Cyclosporine
    Neoral
    Tacrolimus
    Rapamycin
    Mycophenolate
    Everolimus
    Diacerein
    Mizoribine
    Gusperimus
    Etanercept
    Muromonab-CD3
    Cyclophosphamide
    Fingolimod
    Leflunomide
    Imiquimod
    Chloroquinum
    Methotrexate
Immune system drugs Market, by Immunoregulants
    Inosine pranobex
    Melotonin
    Killer helper factor,KHF
    Thymopentin
    Interleukin
    ?-globulin
    Interferon
    Ubenimex 
    Pidotimod
    Thymopentin

Immune system drugs Market, by Key Consumer
    Internal Medicine
    Department of surgery
    Infections Department
    Hospital

 Table of Contents

Global Immune system drugs Market Research Report 2017-2022 by Players, Regions, Product Types & Applications
Chapter One Methodology and Data Source
    1.1 Methodology/Research Approach
        1.1.1 Research Programs/Design
        1.1.2 Market Size Estimation
        1.1.3 Market Breakdown and Data Triangulation
    1.2 Data Source
        1.2.1 Secondary Sources
        1.2.2 Primary Sources
    1.3 Disclaimer

Chapter Two Immune system drugs Market Overview
    2.1 Market Coverage
    2.2 Global Immune system drugs Market Sales Volume Revenue and Price 2012-2017

Chapter Three Immune system drugs by Key Players 2012-2017
    3.1 Global Immune system drugs Sales Volume Market Share by Key Players 2012-2017
    3.2 Global Immune system drugs Revenue Share by Key Players 2012-2017
    3.3 Global Key Players Immune system drugs Key Product Model and Market Performance
    3.4 Global Key Players Immune system drugs Key Target Consumers and Market Performance

Chapter Four Immune system drugs by Regions 2012-2017
    4.1 Global Immune system drugs Sales Market Share by Regions 2012-2017
    4.2 Global Immune system drugs Revenue Market Share by Regions 2012-2017
    4.3 Global Immune system drugs Price by Regions 2012-2017
    4.4 North America
        4.4.1 United States
        4.4.2 Canada
    4.5 Latin America
        4.5.1 Mexico
        4.5.2 Brazil
        4.5.3 Argentina
        4.5.4 Others in Latin America
    4.6 Europe
        4.6.1 Germany
        4.6.2 United Kingdom
        4.6.3 France
        4.6.4 Italy
        4.6.5 Spain
        4.6.6 Russia
        4.6.7 Netherland
        4.6.8 Others in Europe
    4.7 Asia & Pacific
        4.7.1 China
        4.7.2 Japan
        4.7.3 India
        4.7.4 Korea
        4.7.5 Australia
        4.7.6 Southeast Asia
            4.7.6.1 Indonesia
            4.7.6.2 Thailand
            4.7.6.3 Philippines
            4.7.6.4 Vietnam
            4.7.6.5 Singapore
            4.7.6.6 Malaysia
            4.7.6.7 Others in Southeast Asia
    4.8 Africa & Middle East
        4.8.1 South Africa
        4.8.2 Egypt
        4.8.3 Turkey
        4.8.4 Saudi Arabia
        4.8.5 Iran
        4.8.6 Others in Africa & Middle East

Chapter Five Immune system drugs Market by Product Types
    5.1 Immune system drugs, by Immunosuppressive drugs 2012-2017
        5.1.1 Global Immune system drugs Sales Market Share by Immunosuppressive drugs 2012-2017
        5.1.2 Global Immune system drugs Revenue Market Share by Immunosuppressive drugs 2012-2017
        5.1.3 Global Immune system drugs Price by Immunosuppressive drugs 2012-2017
        5.1.4 Azathioprine
        5.1.5 Tripterygium Glycosides
        5.1.6 Cyclosporine
        5.1.7 Sandimmune
        5.1.8 Ciclosporin
              Cyclosporine
              Neoral
              Tacrolimus
              Rapamycin
              Mycophenolate
              Everolimus
              Diacerein
              Mizoribine
              Gusperimus
              Etanercept
              Muromonab-CD3
              Cyclophosphamide
              Fingolimod
              Leflunomide
              Imiquimod
              Chloroquinum
              Methotrexate
    5.2 Immune system drugs, by Immunoregulants 2012-2017
        5.2.1 Global Immune system drugs Sales Market Share by Immunoregulants 2012-2017
        5.2.2 Global Immune system drugs Revenue Market Share by Immunoregulants 2012-2017
        5.2.3 Global Immune system drugs Price by Immunoregulants 2012-2017
        5.2.4 Inosine pranobex
        5.2.5 Melotonin
        5.2.6 Killer helper factor,KHF
        5.2.7 Thymopentin
        5.2.8 Interleukin
              ?-globulin
              Interferon
              Ubenimex 
              Pidotimod
              Thymopentin

Chapter Six Global Key Players Profile
    6.1 ABBVIE
        6.1.1 ABBVIE Company Details and Competitors
        6.1.2 ABBVIE Key Immune system drugs Models and Performance
        6.1.3 ABBVIE Immune system drugs Business SWOT Analysis and Forecast
        6.1.4 ABBVIE Immune system drugs Sales Volume Revenue Price Cost and Gross Margin
    6.2 ACCORD HLTHCARE
        6.2.1 ACCORD HLTHCARE Company Details and Competitors
        6.2.2 ACCORD HLTHCARE Key Immune system drugs Models and Performance
        6.2.3 ACCORD HLTHCARE Immune system drugs Business SWOT Analysis and Forecast
        6.2.4 ACCORD HLTHCARE Immune system drugs Sales Volume Revenue Price Cost and Gross Margin
    6.3 AKORN INC
        6.3.1 AKORN INC Company Details and Competitors
        6.3.2 AKORN INC Key Immune system drugs Models and Performance
        6.3.3 AKORN INC Immune system drugs Business SWOT Analysis and Forecast
        6.3.4 AKORN INC Immune system drugs Sales Volume Revenue Price Cost and Gross Margin
    6.4 ALLERGAN
        6.4.1 ALLERGAN Company Details and Competitors
        6.4.2 ALLERGAN Key Immune system drugs Models and Performance
        6.4.3 ALLERGAN Immune system drugs Business SWOT Analysis and Forecast
        6.4.4 ALLERGAN Immune system drugs Sales Volume Revenue Price Cost and Gross Margin
    6.5 AMNEAL PHARMS LLC
        6.5.1 AMNEAL PHARMS LLC Company Details and Competitors
        6.5.2 AMNEAL PHARMS LLC Key Immune system drugs Models and Performance
        6.5.3 AMNEAL PHARMS LLC Immune system drugs Business SWOT Analysis and Forecast
        6.5.4 AMNEAL PHARMS LLC Immune system drugs Sales Volume Revenue Price Cost and Gross Margin
    6.6 ANTARES PHARMA INC
        6.6.1 ANTARES PHARMA INC Company Details and Competitors
        6.6.2 ANTARES PHARMA INC Key Immune system drugs Models and Performance
        6.6.3 ANTARES PHARMA INC Immune system drugs Business SWOT Analysis and Forecast
        6.6.4 ANTARES PHARMA INC Immune system drugs Sales Volume Revenue Price Cost and Gross Margin
    6.7 APOTEX
        6.7.1 APOTEX Company Details and Competitors
        6.7.2 APOTEX Key Immune system drugs Models and Performance
        6.7.3 APOTEX Immune system drugs Business SWOT Analysis and Forecast
        6.7.4 APOTEX Immune system drugs Sales Volume Revenue Price Cost and Gross Margin
    6.8 ASTELLAS
        6.8.1 ASTELLAS Company Details and Competitors
        6.8.2 ASTELLAS Key Immune system drugs Models and Performance
        6.8.3 ASTELLAS Immune system drugs Business SWOT Analysis and Forecast
        6.8.4 ASTELLAS Immune system drugs Sales Volume Revenue Price Cost and Gross Margin
    6.9 BAXTER HLTHCARE
        6.9.1 BAXTER HLTHCARE Company Details and Competitors
        6.9.2 BAXTER HLTHCARE Key Immune system drugs Models and Performance
        6.9.3 BAXTER HLTHCARE Immune system drugs Business SWOT Analysis and Forecast
        6.9.4 BAXTER HLTHCARE Immune system drugs Sales Volume Revenue Price Cost and Gross Margin
    6.10 BAYER HEALTHCARE PHARMS
        6.10.1 BAYER HEALTHCARE PHARMS Company Details and Competitors
        6.10.2 BAYER HEALTHCARE PHARMS Key Immune system drugs Models and Performance
        6.10.3 BAYER HEALTHCARE PHARMS Immune system drugs Business SWOT Analysis and Forecast
        6.10.4 BAYER HEALTHCARE PHARMS Immune system drugs Sales Volume Revenue Price Cost and Gross Margin
    6.11 DAVA PHARMS INC
    6.12 DR REDDYS LABS LTD
    6.13 FRESENIUS KABI USA
    6.14 GLENMARK GENERICS
    6.15 HOSPIRA
    6.16 IVAX SUB TEVA PHARMS
    6.17 MAYNE PHARMA
    6.18 MYLAN
    6.19 NOVARTIS
    6.20 ROCHE PALO
    6.21 SANDOZ
    6.22 SANOFI AVENTIS US
    6.23 STRIDES PHARMA
    6.24 TEVA PHARMS
    6.25 VELOXIS PHARMS INC
    6.26 VIDARA THERAPEUTICS RESEARCH LTD
    6.27 VINTAGE PHARMS LLC
    6.28 WATSON LABS
    6.29 WEST-WARD PHARMS INT
    6.30 ZYDUS PHARMS USA

Chapter Seven Immune system drugs by Appliance 2012-2017
    7.1 Global Immune system drugs Sales Market Share by Appliance 2012-2017
    7.2 Internal Medicine
    7.3 Department of surgery
    7.4 Infections Department
    7.5 Hospital
    7.6 Consuming Habit and Preference

Chapter Eight Industry Chain and Supply Chain
    8.1 Immune system drugs Industry Chain Structure
        8.1.1 R&D
        8.1.2 Raw Materials (Components)
        8.1.3 Manufacturing Plants
        8.1.4 Regional Trading (Import Export and Local Sales)
        8.1.5 Online Sales Channel
        8.1.6 Offline Channel
        8.1.7 End Users
    8.2 Immune system drugs Manufacturing
        8.2.1 Key Components
        8.2.2 Assembly Manufacturing
    8.3 Consumer Preference
    8.4 Behavioral Habits
    8.5 Marketing Environment

Chapter Nine Global Immune system drugs Market Size (Sales and Revenue) Forecast (2017-2022)
    9.1 Global Immune system drugs Sales (), Revenue (Million USD) Forecast (2017-2022)
    9.2 Global Immune system drugs Sales () Forecast by Regions (2017-2022)
    9.3 Global Immune system drugs Sales () Forecast by Application (2017-2022)
    9.4 Global Immune system drugs Sales () Forecast by Immunosuppressive drugs (2017-2022)
    9.5 Global Immune system drugs Sales () Forecast by Immunoregulants (2017-2022)

Chapter Ten Development Trend and Research Conclusion
    10.1 Development Trend
    10.2 Research Conclusion

List of Tables and Figures

    Table Global Immune system drugs Sales Volume (), Revenue (Million USD) and Price ()(2012-2017)
    Figure Global Immune system drugs Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Global Immune system drugs Sales Volume () and Growth Rate (2012-2017)
    Table Global Immune system drugs Sales Volume () by Key Players (2012-2017)
    Table Global Immune system drugs Sales Volume Market Share by Key Players (2012-2017)
    Figure Global Immune system drugs Sales Volume Market Share by Key Players 2016
    Figure Global Immune system drugs Sales Volume Market Share by Key Players 2017
    Table Global Immune system drugs Revenue (Million USD) by Key Players (2012-2017)
    Table Global Immune system drugs Revenue Market Share by Key Players (2012-2017)
    Figure Global Immune system drugs Revenue Market Share by Key Players 2016
    Figure Global Immune system drugs Revenue Market Share by Key Players 2017
    Table Global Key Players Key Product Model and Market Performance
    Table Global Key Players Key Target Consumers and Market Performance
    Table Global Immune system drugs Sales () by Regions (2012-2017)
    Table Global Immune system drugs Sales Share by Regions (2012-2017)
    Figure Global Immune system drugs Sales Market Share by Regions in 2016
    Figure Global Immune system drugs Sales Market Share by Regions in 2017
    Table Global Immune system drugs Revenue (Million USD) by Regions (2012-2017)
    Table Global Immune system drugs Revenue Market Share by Regions (2012-2017)
    Figure Global Immune system drugs Revenue Market Share by Regions in 2016
    Figure Global Immune system drugs Revenue Market Share by Regions in 2017
    Table Global Immune system drugs Price () by Regions (2012-2017)
    Table North America Immune system drugs Sales () by Regions (2012-2017)
    Table North America Immune system drugs Revenue (Million USD) by Regions (2012-2017)
    Table North America Immune system drugs Sales Volume () by Key Players 2012-2017
    Figure North America Immune system drugs Sales () and Growth Rate (2012-2017)
    Table Latin America Immune system drugs Sales () by Regions (2012-2017)
    Table Latin America Immune system drugs Revenue (Million USD) by Regions (2012-2017)
    Table Latin America Immune system drugs Sales Volume () by Key Players (2012-2017)
    Figure Latin America Immune system drugs Sales () and Growth Rate (2012-2017)
    Table Europe Immune system drugs Sales () by Regions (2012-2017)
    Table Europe Immune system drugs Revenue (Million USD) by Regions (2012-2017)
    Table Europe Immune system drugs Sales Volume () by Key Players (2012-2017)
    Figure Europe Immune system drugs Sales () and Growth Rate (2012-2017)
    Table Asia & Pacific Immune system drugs Sales () by Regions (2012-2017)
    Table Asia & Pacific Immune system drugs Revenue (Million USD) by Regions (2012-2017)
    Table Asia & Pacific Immune system drugs Sales Volume () by Key Players (2012-2017)
    Figure Asia & Pacific Immune system drugs Sales () and Growth Rate (2012-2017)
    Table Africa & Middle East Immune system drugs Sales () by Regions (2012-2017)
    Table Africa & Middle East Immune system drugs Revenue (Million USD) by Regions (2012-2017)
    Table Africa & Middle East Immune system drugs Sales Volume () by Key Players (2012-2017)
    Figure Africa & Middle East Immune system drugs Sales () and Growth Rate (2012-2017)
    Table Global Immune system drugs Sales () by Immunosuppressive drugs (2012-2017)
    Table Global Immune system drugs Sales Market Share by Immunosuppressive drugs (2012-2017)
    Figure Global Immune system drugs Sales Market Share by Immunosuppressive drugs in 2016
    Table Global Immune system drugs Revenue (Million USD) by Immunosuppressive drugs (2012-2017)
    Table Global Immune system drugs Revenue Market Share by Immunosuppressive drugs (2012-2017)
    Figure Global Immune system drugs Revenue Market Share by Immunosuppressive drugs in 2016
    Table Global Immune system drugs Price () by Immunosuppressive drugs (2012-2017)
    Table Top Players of Azathioprine Immune system drugs Products List
    Figure Global Azathioprine Immune system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Tripterygium Glycosides Immune system drugs Products List
    Figure Global Tripterygium Glycosides Immune system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Cyclosporine Immune system drugs Products List
    Figure Global Cyclosporine Immune system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Sandimmune Immune system drugs Products List
    Figure Global Sandimmune Immune system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Ciclosporin Immune system drugs Products List
    Figure Global Ciclosporin Immune system drugs Sales () and Growth Rate (2012-2017)
    Table Global Immune system drugs Sales () by Immunoregulants (2012-2017)
    Table Global Immune system drugs Sales Market Share by Immunoregulants (2012-2017)
    Figure Global Immune system drugs Sales Market Share by Immunoregulants in 2016
    Table Global Immune system drugs Revenue (Million USD) by Immunoregulants (2012-2017)
    Table Global Immune system drugs Revenue Market Share by Immunoregulants (2012-2017)
    Figure Global Immune system drugs Revenue Market Share by Immunoregulants in 2016
    Table Global Immune system drugs Price () by Immunoregulants (2012-2017)
    Table Top Players of Inosine pranobex Immune system drugs Products List
    Figure Global Inosine pranobex Immune system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Melotonin Immune system drugs Products List
    Figure Global Melotonin Immune system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Killer helper factor,KHF Immune system drugs Products List
    Figure Global Killer helper factor,KHF Immune system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Thymopentin Immune system drugs Products List
    Figure Global Thymopentin Immune system drugs Sales () and Growth Rate (2012-2017)
    Table Top Players of Interleukin Immune system drugs Products List
    Figure Global Interleukin Immune system drugs Sales () and Growth Rate (2012-2017)
    Table Global Immune system drugs Sales () by  (2012-2017)
    Table Global Immune system drugs Sales Market Share by  (2012-2017)
    Figure Global Immune system drugs Sales Market Share by  in 2016
    Table Global Immune system drugs Revenue (Million USD) by  (2012-2017)
    Table Global Immune system drugs Revenue Market Share by  (2012-2017)
    Figure Global Immune system drugs Revenue Market Share by  in 2016
    Table Global Immune system drugs Price () by  (2012-2017)
    Table Global Immune system drugs Sales () by  (2012-2017)
    Table Global Immune system drugs Sales Market Share by  (2012-2017)
    Figure Global Immune system drugs Sales Market Share by  in 2016
    Table Global Immune system drugs Revenue (Million USD) by  (2012-2017)
    Table Global Immune system drugs Revenue Market Share by  (2012-2017)
    Figure Global Immune system drugs Revenue Market Share by  in 2016
    Table Global Immune system drugs Price () by  (2012-2017)
    Table ABBVIE Company Details and Competitors
    Table ABBVIE Key Immune system drugs Models and Performance
    Table ABBVIE Immune system drugs Business SWOT Analysis and Forecast
    Table ABBVIE Immune system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure ABBVIE Immune system drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure ABBVIE Immune system drugs Sales Market Share (%) in Global (2012-2017)
    Figure ABBVIE Immune system drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure ABBVIE Immune system drugs Revenue Market Share (%) in Global (2012-2017)
    Table ACCORD HLTHCARE Company Details and Competitors
    Table ACCORD HLTHCARE Key Immune system drugs Models and Performance
    Table ACCORD HLTHCARE Immune system drugs Business SWOT Analysis and Forecast
    Table ACCORD HLTHCARE Immune system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure ACCORD HLTHCARE Immune system drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure ACCORD HLTHCARE Immune system drugs Sales Market Share (%) in Global (2012-2017)
    Figure ACCORD HLTHCARE Immune system drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure ACCORD HLTHCARE Immune system drugs Revenue Market Share (%) in Global (2012-2017)
    Table AKORN INC Company Details and Competitors
    Table AKORN INC Key Immune system drugs Models and Performance
    Table AKORN INC Immune system drugs Business SWOT Analysis and Forecast
    Table AKORN INC Immune system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure AKORN INC Immune system drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure AKORN INC Immune system drugs Sales Market Share (%) in Global (2012-2017)
    Figure AKORN INC Immune system drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure AKORN INC Immune system drugs Revenue Market Share (%) in Global (2012-2017)
    Table ALLERGAN Company Details and Competitors
    Table ALLERGAN Key Immune system drugs Models and Performance
    Table ALLERGAN Immune system drugs Business SWOT Analysis and Forecast
    Table ALLERGAN Immune system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure ALLERGAN Immune system drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure ALLERGAN Immune system drugs Sales Market Share (%) in Global (2012-2017)
    Figure ALLERGAN Immune system drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure ALLERGAN Immune system drugs Revenue Market Share (%) in Global (2012-2017)
    Table AMNEAL PHARMS LLC Company Details and Competitors
    Table AMNEAL PHARMS LLC Key Immune system drugs Models and Performance
    Table AMNEAL PHARMS LLC Immune system drugs Business SWOT Analysis and Forecast
    Table AMNEAL PHARMS LLC Immune system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure AMNEAL PHARMS LLC Immune system drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure AMNEAL PHARMS LLC Immune system drugs Sales Market Share (%) in Global (2012-2017)
    Figure AMNEAL PHARMS LLC Immune system drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure AMNEAL PHARMS LLC Immune system drugs Revenue Market Share (%) in Global (2012-2017)
    Table ANTARES PHARMA INC Company Details and Competitors
    Table ANTARES PHARMA INC Key Immune system drugs Models and Performance
    Table ANTARES PHARMA INC Immune system drugs Business SWOT Analysis and Forecast
    Table ANTARES PHARMA INC Immune system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure ANTARES PHARMA INC Immune system drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure ANTARES PHARMA INC Immune system drugs Sales Market Share (%) in Global (2012-2017)
    Figure ANTARES PHARMA INC Immune system drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure ANTARES PHARMA INC Immune system drugs Revenue Market Share (%) in Global (2012-2017)
    Table APOTEX Company Details and Competitors
    Table APOTEX Key Immune system drugs Models and Performance
    Table APOTEX Immune system drugs Business SWOT Analysis and Forecast
    Table APOTEX Immune system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure APOTEX Immune system drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure APOTEX Immune system drugs Sales Market Share (%) in Global (2012-2017)
    Figure APOTEX Immune system drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure APOTEX Immune system drugs Revenue Market Share (%) in Global (2012-2017)
    Table ASTELLAS Company Details and Competitors
    Table ASTELLAS Key Immune system drugs Models and Performance
    Table ASTELLAS Immune system drugs Business SWOT Analysis and Forecast
    Table ASTELLAS Immune system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure ASTELLAS Immune system drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure ASTELLAS Immune system drugs Sales Market Share (%) in Global (2012-2017)
    Figure ASTELLAS Immune system drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure ASTELLAS Immune system drugs Revenue Market Share (%) in Global (2012-2017)
    Table BAXTER HLTHCARE Company Details and Competitors
    Table BAXTER HLTHCARE Key Immune system drugs Models and Performance
    Table BAXTER HLTHCARE Immune system drugs Business SWOT Analysis and Forecast
    Table BAXTER HLTHCARE Immune system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure BAXTER HLTHCARE Immune system drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure BAXTER HLTHCARE Immune system drugs Sales Market Share (%) in Global (2012-2017)
    Figure BAXTER HLTHCARE Immune system drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure BAXTER HLTHCARE Immune system drugs Revenue Market Share (%) in Global (2012-2017)
    Table BAYER HEALTHCARE PHARMS Company Details and Competitors
    Table BAYER HEALTHCARE PHARMS Key Immune system drugs Models and Performance
    Table BAYER HEALTHCARE PHARMS Immune system drugs Business SWOT Analysis and Forecast
    Table BAYER HEALTHCARE PHARMS Immune system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure BAYER HEALTHCARE PHARMS Immune system drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure BAYER HEALTHCARE PHARMS Immune system drugs Sales Market Share (%) in Global (2012-2017)
    Figure BAYER HEALTHCARE PHARMS Immune system drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure BAYER HEALTHCARE PHARMS Immune system drugs Revenue Market Share (%) in Global (2012-2017)
    Table DAVA PHARMS INC Company Details and Competitors
    Table DR REDDYS LABS LTD Company Details and Competitors
    Table FRESENIUS KABI USA Company Details and Competitors
    Table GLENMARK GENERICS Company Details and Competitors
    Table HOSPIRA Company Details and Competitors
    Table IVAX SUB TEVA PHARMS Company Details and Competitors
    Table MAYNE PHARMA Company Details and Competitors
    Table MYLAN Company Details and Competitors
    Table NOVARTIS Company Details and Competitors
    Table ROCHE PALO Company Details and Competitors
    Table SANDOZ Company Details and Competitors
    Table SANOFI AVENTIS US Company Details and Competitors
    Table STRIDES PHARMA Company Details and Competitors
    Table TEVA PHARMS Company Details and Competitors
    Table VELOXIS PHARMS INC Company Details and Competitors
    Table VIDARA THERAPEUTICS RESEARCH LTD Company Details and Competitors
    Table VINTAGE PHARMS LLC Company Details and Competitors
    Table WATSON LABS Company Details and Competitors
    Table WEST-WARD PHARMS INT Company Details and Competitors
    Table ZYDUS PHARMS USA Company Details and Competitors
    Table Global Immune system drugs Sales () by Appliance (2012-2017)
    Figure Global Immune system drugs Sales Market Share by Appliance (2012-2017)
    Figure Global Immune system drugs Sales Market Share by Appliance in 2016
    Figure Global Internal Medicine Immune system drugs Sales () and Growth Rate (2012-2017)
    Figure Global Department of surgery Immune system drugs Sales () and Growth Rate (2012-2017)
    Figure Global Infections Department Immune system drugs Sales () and Growth Rate (2012-2017)
    Figure Global Hospital Immune system drugs Sales () and Growth Rate (2012-2017)
    Figure Global Immune system drugs Sales () and Growth Rate (%) Forecast (2017-2022)
    Figure Global Immune system drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Global Immune system drugs Price () Trend Forecast (2017-2022)
    Table Global Immune system drugs Sales () Forecast by Regions (2017-2022)
    Table Global Immune system drugs Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Immune system drugs Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Immune system drugs Sales Volume Share Forecast by Regions in 2022
    Table Global Immune system drugs Sales () Forecast by Application (2017-2022)
    Figure Global Immune system drugs Sales Volume Market Share Forecast by Application (2017-2022)
    Figure Global Immune system drugs Sales Volume Market Share Forecast by Application in 2022
    Table Global Immune system drugs Sales () Forecast by Immunosuppressive drugs (2017-2022)
    Figure Global Immune system drugs Sales () Forecast by Immunosuppressive drugs (2017-2022)
    Figure Global Immune system drugs Sales Volume Market Share Forecast by Immunosuppressive drugs in 2022
    Table Global Immune system drugs Sales () Forecast by Immunoregulants (2017-2022)
    Figure Global Immune system drugs Sales () Forecast by Immunoregulants (2017-2022)
    Figure Global Immune system drugs Sales Volume Market Share Forecast by Immunoregulants in 2022